A model that included only MMSE test score and the AD CSF biomarkers (Aβ42, t-tau, and p-tau) but not the cholinergic markers had a predictability of 70, 72, and 71% for the diagnoses of SCI, MCI, and AD, respectively. The gene discussed is MAPT; the disease is Alzheimer disease.